Evidence map›Paper›PMID 41364688›Full record

ArticlePloS one2025

Chronobiological analysis of sex differences in electrocardiographic parameters in spontaneously breathing Wistar rats under tiletamine-zolazepam anaesthesia.

Viktória Novotná, Soňa Grešová, Pavol Švorc

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Viktória NovotnáDepartment of Medical Physiology, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovak Republic.ORCID https://orcid.org/0009-0003-1624-5010
Soňa GrešováDepartment of Medical Physiology, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovak Republic.
Pavol ŠvorcDepartment of Medical Physiology, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovak Republic.ORCID https://orcid.org/0000-0002-6890-2161

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGeneral anaesthesia is essential in surgical interventions because it reduces stress and restricts the animal's movement. However, it can interfere with the circadian clock and, consequently, with several physiological functions, including the cardiovascular system. A combination of tiletamine and zolazepam is rarely used in rat studies; therefore, its effect on cardiovascular function in the context of sex and the light/dark cycle remains unknown.

aimThis study analysed the effect of sex and the light/dark cycle on electrocardiographic parameters in Wistar rats anaesthetised with tiletamine-zolazepam.

methodsExperiments were performed on spontaneously breathing Wistar rats of both sexes following a 4-week adaptation to a light/dark (12h/12h) cycle. After intraperitoneal administration of Zoletil 50 (30 mg/kg; Virbac; France), electrocardiographic parameters were measured in lead II using LabChart 8 (ID Instruments).

resultsRegarding the effect of the light/dark cycle on electrocardiographic parameters, males showed a higher heart rate and a shorter PR interval during the dark period, whereas females exhibited a longer QRS interval and a higher R wave amplitude in the dark period than in the light period. Sexual dimorphism was present during the light period, with males showing a longer QT interval and females displaying a higher T wave amplitude. In the dark period, sex differences were observed only in the PR interval, which was shorter in males.

conclusionThe obtained results indicate a significant effect of sex and light/dark cycle on cardiovascular parameters in rats under tiletamine-zolazepam.

Indexed as

ElectrocardiographyRespirationSex CharacteristicsTiletamineZolazepamAnimalsCircadian RhythmDrug CombinationsFemaleHeart RateMaleRatsRats, WistarDrug CombinationsTiletaminetiletamine, zolazepam drug combinationZolazepam

Identifiers

PMID41364688
PMCPMC12688129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.